1 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Dent Disease: new trials by email Literature Review of Dent Disease trials Research Report on Dent Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role Of Phosphorus And FGF 23 In Patients With Dent Disease Phosphorus Supplement, Observation - Dent Disease | Phase 1 / Phase 2 | Completed | Mayo Clinic | 30 | 2014-09-01 | 2020-03-23 |
| Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria Hydrochlorothiazide - Dent's Disease, Nephrolithiasis | Phase 2 / Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 10 | 2003-07-01 | 2008-03-19 |
Nephrolithiasis (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Genetic Diseases, X-Linked (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Renal Tubular Transport, Inborn Errors (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urolithiasis (1)
Hydrochlorothiazide (1) · Observation (1)
Assistance Publique - Hôpitaux de Paris (1) · Mayo Clinic (1)
France (1) · United States (1)